Napspas M 80mg/250mg Tablet
Marketer
Raddison Health Care Pvt Ltd
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Napspas M 80mg/250mg Tablet
Abdominal pain relief is provided by the combined medication, Napspas M 80mg/250mg Tablet. This formulation effectively lessens abdominal pain, bloating, discomfort, and cramping by inducing relaxation in the stomach and intestinal muscles. It also inhibits specific pain-inducing chemical signals. Dosage and treatment duration for Napspas M 80mg/250mg Tablet, taken with food, should strictly follow your physician's instructions. Your prescribed dose will depend on your individual response and condition. Continue taking this medication as directed by your doctor; premature discontinuation may lead to symptom recurrence and condition worsening. Inform your healthcare provider of all other medications you are currently using, as interactions are possible. Common side effects, such as diarrhea, nausea, vomiting, stomach pain, dry mouth, appetite loss, thirst, and heartburn, are typically transient. However, report any concerning side effects to your doctor immediately. Dizziness and drowsiness are also possible; refrain from driving or mentally demanding tasks until you assess the medicine's effect. Avoid alcohol consumption during treatment to minimize dizziness. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding before starting this medication. Kidney or liver conditions should also be disclosed to ensure appropriate dosage.
Uses of Napspas M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Napspas M 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Napspas M 80mg/250mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
Common Side effects of Napspas M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Napspas M 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Napspas M 80mg/250mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Napspas M 80mg/250mg Tablet works:
Napspas M 80mg/250mg tablets combine drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms by reducing contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for abdominal pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Combining Napspas M 80mg/250mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Napspas M 80mg/250mg Tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against the risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Napspas M 80mg/250mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Napspas M 80mg/250mg Tablets, a potential side effect of this medication, as it can induce dizziness.
KidneyCAUTION
Individuals with impaired kidney function should use Napspas M 80mg/250mg tablets cautiously, potentially requiring a modified dosage. Medical advice is necessary. Napspas M 80mg/250mg tablets are unsuitable for patients exhibiting severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Napspas M 80mg/250mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Napspas M 80mg/250mg Tablet :
Should you forget a Napspas M 80mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Napspas M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently